Successful radioiodine redifferentiation with selpercatinib in RET fusion-positive papillary thyroid carcinoma

Ethics approval

Libretto-001 trial has ethics approval.

Consent to participate and publish

Written informed consent was obtained from the patient.

Competing interests

Daniela Weiler has received speaker and consultant honoraria from Eli Lilly. Maria del Sol Pérez Lago declares no financial interests.

留言 (0)

沒有登入
gif